Refine your search
Collections
Co-Authors
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Vora, A.
- Clinical Study of Hypertension in Young Adults
Abstract Views :210 |
PDF Views:0
Authors
Affiliations
1 Department of Medicine, Bharati Vidyapeeth Deemed University, Medical College and Bharati Hospital, Pune, 411002, IN
2 Department of Medicine, Bharati Vidyapeeth Deemed University, Medical College and Bharati Hospital, Pune, IN
1 Department of Medicine, Bharati Vidyapeeth Deemed University, Medical College and Bharati Hospital, Pune, 411002, IN
2 Department of Medicine, Bharati Vidyapeeth Deemed University, Medical College and Bharati Hospital, Pune, IN
Source
The Indian Practitioner, Vol 69, No 4 (2016), Pagination: 28-32Abstract
This prospective study was undertaken in 40 patients of hypertension in the age group of 18 - 40 years, randomly selected from the in and outdoor patient department over a period of two years. The aim was to study the clinical profile, associated risk factors, assess the target organ damage and identify the causes of hypertension in young adults.In conclusion a definite male preponderance with a male to female ratio of 1.35:1, especially stage II hypertension. 77.5% patients showed target organ damage in the present study (Hypertensive retinopathy), incidence of LVH was seen in 40%. The commonest cause of secondary hypertension observed was renal parenchymal disease (44.44%). The relative possibility of the hypertension being secondary was increased, which had a distinct possibility of cure.
Keywords
Secondary Hypertension, Young Adults, Risk Factors, Target Organ Damage.- Valproate Causing Recurrent Acute Pancreatitis
Abstract Views :215 |
PDF Views:3
Authors
Affiliations
1 Dept. of Medicine, Bharati Vidyapeeth Deemed University Medical College and Hospital, Pune, Maharashtra, IN
2 Dept, of Medicine, Bharati Vidyapeeth Deemed University Medical College and Hospital, Pune, Maharashtra, IN
1 Dept. of Medicine, Bharati Vidyapeeth Deemed University Medical College and Hospital, Pune, Maharashtra, IN
2 Dept, of Medicine, Bharati Vidyapeeth Deemed University Medical College and Hospital, Pune, Maharashtra, IN
Source
The Indian Practitioner, Vol 70, No 8 (2017), Pagination: 36-38Abstract
Valproic acid is used either as monotherapy or in combination with other anticonvulsants for the treatment of simple, mixed and complex partial seizures, myoclonic seizure, generalised tonic- clonic seizure, acute manic episodes in bipolar disorder, and for prophylaxis of migraine headaches. The association of sodium valproate and pancreatitis is sometimes referred to as idiosyncratic as pancreatitis can develop after 1 week to 8 years of exposure to sodium valproate. We report a case of 39 year old male known case of seizure disorder presenting with recurrent episodes of epigatrium and right hypochondrium abdominal pain associated with vomiting over a period of 4 years. After excluding other causes of pancreatitis, a diagnosis of valproate induced necrotising pancreatitis was established.Keywords
Valproic Acid, Pancreatitis.References
- Pancreatitis associated with valproic acid: a review of the literature. Chapman SA, Wacksman GP, Patterson BD. Pharmacotherapy. 2001;21:1549– 1560.
- Idiosyncratic adverse reactions to antiepileptic drugs. Zaccara G, Franciotta D, Perucca E. Epilepsia.2007;48:1223–1244.
- Gerstner T, Büsing D, Bell N. et al. Valproic acidinduced pancreatitis:16 new cases and a review of the literature. J Gastroenterol. 2007;42(1):39–48.
- Wilmink T, Frick WK. Drug induced pancreatitis. Drug safety 1996; 14: 406-423.
- Pancreatitis associated with valproic acid therapy. Batalden PB, Van Dyne BJ, Cloyd J. Pediatrics.1979;64:520–522.
- Pancreatitis due to valproic acid. Camfield PR, Bagnell P, Camfield CS, Tibbles JA. Lancet. 1979;1:1198–1199.
- Hamad AE, Fawzi ME. Valproate associated acute pancreatitis. Neurosciences. 2000;5(3):156–8.
- The role of oxygen-derived free radicals in the pathogenesis of acute pancreatitis. Sanfey H, Bulkley GB, Cameron JL. Ann Surg. 1984;200:405– 413.
- Acute pancreatitis coincident with valproate use: a critical review. Pellock JM, Wilder BJ, Deaton R, Sommerville KW. Epilepsia. 2002;43:1421–1424.
- Carnitine levels in valproic acid-treated psychiatric patients: a cross-sectional study. Moreno FA, Macey H, Schreiber B. J Clin Psychiatry. 2005;66:555–558.
- The spectrum of valproic acid-associated pancreatitis. Werlin SL, Fish DL. Pediatrics. 2006;118:1660– 1663.
- Climate Change and the Patent Regime:Are Patents the Answer?
Abstract Views :163 |
PDF Views:112
Authors
Affiliations
1 Jindal Global University, Sonipat Narela Road, Sonipat, Haryana 131 001, Haryana, IN
1 Jindal Global University, Sonipat Narela Road, Sonipat, Haryana 131 001, Haryana, IN
Source
Journal of Intellectual Property Rights, Vol 23, No 1 (2018), Pagination: 22-26Abstract
Next to nuclear annihilation, climate change poses the greatest threat to life as we know it. Climate refugees are becoming a reality and it is expected that by 2050 most of the Pacific Islands will be under water. Forward-thinking nations have made it their agenda to curb the effects of climate change and ensure the reduction in emissions of greenhouse gases.1 To effectively combat climate change, the deployment of clean energy technologies to combat the effect of carbon emissions from fossil fuelshas been the tool of choice.2 Accelerated development and deployment of these clean energy technologies is imperative. The public and private sectors must boost the creation and distribution of clean as well as environmentally sound technologies – something along the magnitude and scale of the space race during the cold war. Addressing the threats posed by climate change requires a portfolio of processes such as extensive introduction of new technologies and modification of existing technologies while also creating optimum environments. The role of intellectual property3 pertaining to clean energy technologies becomes of utmost importance. The patent regime, by its very nature, can either be seen as a hindrance or an incentive for the development of new technology.4 This means that an argument can be raised that patents would hinder climate change mitigations as clean technology is patented and licensing it would prove costly. On the other hand, patents will incentivize innovation and therefore lead to advanced technologies to combat climate change.4 The paper, refutes the former and argues that patents are essential and rebut the presumption that patents will increase prices. The paper explains, with examples, how the holy trinity of patent pools, patent databases and compulsory licensing will help make the clean energy technology competitive and accessible. The future and the applicability of fair, reasonable and nondiscriminatory (FRAND) licensing to standardised clean energy technology are also discussed. The paper is concluded with an affirmation that patents are the answer to climate change.Keywords
TRIPS Agreement, World Intellectual Property Organization, RE100, FRAND Licensing, Greenhouse Gases, Clean Energy Technologies, Climate Mitigation, Intellectual Property Rights, Pharmaceutical Industry, Patent Pool, Patent Databases, Compulsory Licensing.References
- Paris Agreement, United Nations, 12 December 2015, (accessed in May 2017).
- James T, The biggest clean energy advances in 2016, MIT Technology Review, 29 December 2016.
- Through the course of the paper we use intellectual property and patents interchangeably as the primary intellectual property right pertinent to clean technology would be patents.
- How patents encourage innovation in technological development and deployment Global CCS Institute.
- Cannady C, Access to Climate Change Technology by Developing Countries, A Practical Strategy, ICTSD’s Programme on IPRs and Sustainable Development, International Centre for Trade and Sustainable Development, Geneva, Switzerland. 25 (2010) 1-10.
- Copenhagen Economics and The IPR Company, Are IPR a Barrier to the Transfer of Climate Change Technology? (19 January 2009).
- Development and Disarmament Roundtable. Climate mitigation and intellectual property in tension, Bulletin of the Atomic Scientists, 04 May 2015.
- Chatterjee P, India: Balancing public and private interests in the intellectual property regime, Intellectual Property Watch, 23 March 2015, www.ip-watch.org/2012/09/18/indiabalancingpublic-and-private-interests-in-the-intellectualpropertyregime/.
- Poonia M, Importance of patents in pharmaceutical industry, 17 December 2015, http://www.pharmabiz.com/ArticleDetails.aspx?aid=92383&sid=21.
- Wines M, China Outlines Ambitious Plan for Stimulus, New York Times, http:// www.nytimes.com/2009/03/05/ world/asia/05china.htm (2009).
- WIPO Magazine, Sharing technology to meet a common challenge: Navigating proposals for patent pools, patent commons and open innovation, WIPO Magazine Issue 2, 4-7 April 2009.
- World Intellectual Property Organization (WIPO) (2008), World Patent Report, World Intellectual Property Organization, Geneva, Switzerland.
- Moyo D, Dead Aid: Why Aid is Not Working and How There Is a Better Way For Africa, Farrar, Straus and Giroux, New York, USA, (2009).
- Public Health FAQ, WTO TRIPS, https://www.wto.org/ english/tratop_e/trips_e/public_health_faq_e.htm (accessed on 11 October 2017).
- Sara M Ford, Compulsory licensing provisions under the TRIPS Agreement: Balancing pills and patents, American University International Law review, 15 (4) (2000) 941, 953. Discussing the long-standing conflict between the right to access life-saving medication and the profit-driven agendas of pharmaceutical companies in restricting such access.
- Chemically known as ‘Sorafenib Tosylate’, the drug is used for the treatment of advanced stage liver and kidney cancer. By stopping the growth of new blood vessels and impacting other cellular growth mechanisms, the drug can extend the life of a patient, the duration being between 6 months and 5 years.
- Bayer Corporation v Natco Pharma Ltd., Order No. 45/2013 (Intellectual Property Appellate Board, Chennai), http://www.ipab.tn.nic.in/045-2013.htm (accessed on 12 May 2013).
- RE 100 Annual Report 2016, http://www.se4all.org/ sites/default/files/RE100-Annual-Report2016.pdf (accessed on 13 October 2017).
- WIPO, Patent Landscapes Reports Project on Solar on Solar Cooking, 2011.
- Abbott F, Innovation and Technology Transfer to Address Climate Change, Lessons from the Global Debate on Intellectual Property and Public Health, Intellectual Property and Sustainable Development Series, Issue Paper Number 24, ICTSD, June 2009, http://ictsd.org/i/publications/50454/.
- Poonia M, Importance of patents in pharmaceutical industry, 17 December 2015, http://www.pharmabiz.com/ ArticleDetails.aspx?aid=92383&sid=21.
- Consumer Protection Concerns As Big Tech Centres the Energy Markets, FORBES, https://www.forbes.com/ sites/uhenergy/2017/09/13/consumer-protection-concerns-asbigtech-enters-the-energy-markets/2/#7849c0c039c9 (accessed on 13 October 2017).
- Sustainable Signals: The Individual Investor Perspective, Morgan Stanley, https://www.morganstanley.com/ sustainableinvesting/pdf/Sustainable_Signals.pdf, (accessed on 13 October 2017).
- Sweeney James L, The California Electricity Crisis: Lessons for the Future, National Academy of Engineering of the Nation Academies, (Summer 2002). https://www.ukessays.com/ essays/engineering/role-enron-collapse-california-4854.php.